North
America dominated the market by contributing more than 75.0% of the share in
2016 and continue to dominate owing to the increasing number of prescriptions
for morphine in the U.S. North American market for the same is expected to grow
at a CAGR of 2.9% over the forecast period. However, lack of availability of
medical morphine in countries such as India is expected to hamper the growth of
the market.
In terms of
route of administration, the oral segment is expected to grow at the fastest
CAGR over the projected period owing to its dose accuracy, high accessibility,
and ease of carrying compared to injectables and other counterparts.
On the
basis of indication, others segment is expected to grow at the fastest CAGR of
3.1% over the forecast period owing to increasing number of prescriptions of
morphine in U.S. for nominal conditions. The cancer segment is expected to
exhibit lucrative growth due to increasing prevalence of bone cancer globally.
Browse
Details of Report @ https://www.hexaresearch.com/research-report/medical-morphine-market
Morphine
with its use in therapeutics is also one of the most abused drug globally.
Respective governments are introducing initiatives to prevent substance abuse
and decrease death rates caused by morphine.
Furthermore,
researchers are concentrating on drug abuse treatment for opioid addicts which
is expected to reduce the illicit use of morphine. For instance, in August
2017, researchers at University of California San Diego in collaboration with
CARI therapeutics commenced development of a biosensor capable of detecting
opioids in human bodies.
Hexa
Research has segmented the global medical morphine market based on Route
of Administration , Indication and region:
Segmentation
by Route of Administration, 2014 - 2024 (USD Million)
• Oral
• Injectables
• Others
• Oral
• Injectables
• Others
Segmentation
by Indication, 2014 - 2024 (USD Million)
• Cancer
• Arthritis
• Others
• Cancer
• Arthritis
• Others
Segmentation
by Region, 2014 - 2024 (USD Million)
• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• China
• India
• Rest of the World
• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• China
• India
• Rest of the World
Key players
analyzed
• Mallinckrodt Pharmaceuticals
• Alcaliber S.A.
• Purdue Pharma L.P.
• Pfizer Inc.
• Johnson Matthey Fine Chemicals
• Sun Pharmaceutical Industries Ltd.
• Verve Health Care Ltd.
• Taj Pharmaceuticals Limited
• NORTHEAST PHARM
• MANUS AKTTEVA BIOPHARMA LLP
• Mallinckrodt Pharmaceuticals
• Alcaliber S.A.
• Purdue Pharma L.P.
• Pfizer Inc.
• Johnson Matthey Fine Chemicals
• Sun Pharmaceutical Industries Ltd.
• Verve Health Care Ltd.
• Taj Pharmaceuticals Limited
• NORTHEAST PHARM
• MANUS AKTTEVA BIOPHARMA LLP
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry
About Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website: https://www.hexaresearch.com
No comments:
Post a Comment